Clinical trial
A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
NCT01553721 is registered in ClinicalTrials.gov with Dong-A ST Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
- Lead sponsor
- Dong-A ST Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- March 31, 2015
- Enrollment
- 63 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.